topotecan has been researched along with Labhart-Willi Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ach, RA; Adams, S; Chédin, F; Coulson, RL; Crary, FK; Gonzales, ML; LaSalle, JM; Powell, WT; Tsang, P; Wong, SS; Yamada, NA; Yasui, DH | 1 |
1 other study(ies) available for topotecan and Labhart-Willi Syndrome
Article | Year |
---|---|
R-loop formation at Snord116 mediates topotecan inhibition of Ube3a-antisense and allele-specific chromatin decondensation.
Topics: Angelman Syndrome; Animals; Chromatin; Chromatin Immunoprecipitation; Chromosomes, Human, Pair 15; Gene Expression Regulation; Gene Silencing; Genetic Loci; Genomic Imprinting; HEK293 Cells; Humans; Immunoblotting; In Situ Hybridization, Fluorescence; Locus Control Region; Mice; Mice, Knockout; Neurons; Prader-Willi Syndrome; Real-Time Polymerase Chain Reaction; RNA, Antisense; RNA, Small Nucleolar; snRNP Core Proteins; Statistics, Nonparametric; Topotecan; Ubiquitin-Protein Ligases | 2013 |